Monoamine oxidase inhibitors (MAOI) are already recognized to prolong and increase the consequences of dimethyltryptamine (copyright) and a single research assumed the effect on psilocybin can be similar since it is often a structural analogue of copyright.[145] Even so, only a small part of psilocin seems to generally be metabolized https://judyk677mhb1.wikistatement.com/user